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Abstract This study examined the effectiveness of heart
rate variability (HRV) biofeedback intervention for
reduction of psychological stress in women in the early
postpartum period. On postpartum day 4, 55 healthy sub-
jects received a brief explanation about HRV biofeedback
using a portable device. Among them, 25 mothers who
agreed to implement HRV biofeedback at home were
grouped as the biofeedback group, and other 30 mothers
were grouped as the control group. At 1 month postpartum,
there was a significant decrease in total Edinburgh Post-
natal Depression Scale score (P \ 0.001) in the biofeed-
back group; this change was brought about mainly by
decreases in items related to anxiety or difficulty sleeping.
There was also a significant increase in standard deviation
of the normal heartbeat interval (P \ 0.01) of the resting
HRV measures in the biofeedback group after adjusting for
potential covariates. In conclusion, postpartum women who
implemented HRV biofeedback after delivery were rela-
tively free from anxiety and complained less of difficulties
sleeping at 1 month postpartum. Although the positive
effects of HRV biofeedback may be partly attributable to
intervention effects, due to its clinical outcome, HRV
biofeedback appears to be recommendable for many post-
partum women as a feasible health-promoting measure
after childbirth.
Keywords Heart rate variability  Biofeedback 
Edinburgh Postnatal Depression Scale  Early postpartum
period  Psychological stress
Introduction
Immediately after delivery, mothers are required to adapt
to a new lifestyle that focuses on childcare. Many
mothers find the process of meeting the demands of their
new lifestyle a joyful experience. However, some mothers
have trouble getting used to the new routines and
responsibilities and experience high stress levels. The
early postpartum period is a critical time during which
women have an increased risk for depression (Cox et al.
1993; Ross and Dennis 2009; Klainin and Arthur 2009).
Therefore, effective interventions that help these women
transition through this stressful period should be
available.
The autonomic nervous system plays an important role
in human stress reactions. During usual stress reactions, the
introduction of a stressor activates the sympathetic nervous
system; the system returns to its former state when the
stress fades. When subjects are exposed to chronic stress
beyond the range where physiological functions are
reversible, their everyday autonomic balance shifts toward
a sympathetic-predominant state as a result of parasym-
pathetic withdrawal. However, this persistent attenuation
of parasympathetic activity may deteriorate the regulatory
capability of physiological functions for external stressors
(Porges 1995; McEwen 2004; Thayer and Sternberg 2006).
In late pregnancy, the balance of the autonomic nervous
system of the resting period is shifted toward a sympa-
thetic-predominant state with parasympathetic withdrawal,
probably due to adaptive responses against hemodynamic
changes and aortocaval compression caused by the
enlarged uterus (Kuo et al. 2000; Walther et al. 2005;
Matsuo et al. 2007). After delivery, this specific condition
rapidly returns to a non-pregnant state, and the recovery
process includes parasympathetic activation. If this
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recovery process does not proceed normally, that is, if
sympathetic-predominant autonomic balance is not
smoothly recovered, postpartum women became more
vulnerable to external stressors and may develop physical
and/or psychiatric disorders.
Heart rate variability (HRV) biofeedback is a training
method to control one’s breathing to the resonate frequency
of about five to six breaths per minute, at which the
amplitude of HRV is maximized; this may strengthen the
baroreflex, thus improving autonomic functioning (Lehrer
et al. 2003; Vaschillo et al. 2006). HRV biofeedback has
been shown to contribute to the treatment of a variety of
diseases with autonomic dysfunctions, including stress-
related psychiatric disorders (Karavidas et al. 2007; Reiner
2008; Siepmann et al. 2008; Zucker et al. 2009; Weber
et al. 2010; Tan et al. 2011; Beckham et al. 2013) or stress-
related chronic pain (Hassett et al. 2007; Hallman et al.
2011). Furthermore, HRV biofeedback may be available as
a stress management method for healthy subjects under
relatively stressful conditions (Henriques et al. 2011; Ra-
tanasiripong et al. 2012; Whited et al. 2014). Theoretically,
HRV biofeedback is beneficial in most mothers whose
autonomic balance tends to shift toward a sympathetic-
predominant state. Some portable devices for HRV bio-
feedback are marketed worldwide (Ebben et al. 2009), and
HRV biofeedback is a feasible intervention during the early
postpartum period. However, it remains questionable
whether HRV biofeedback results in favorable modifica-
tions in autonomic functioning of healthy subjects (Lehrer
and Eddie 2013), and effectiveness of HRV biofeedback in
healthy postpartum women should be carefully verified
before recommending it to mothers as a health-promoting
measure after childbirth.
The objective of the present study was to examine the
effectiveness of HRV biofeedback intervention for reduc-
tion of psychological stress in women in the early post-
partum period. We investigated whether implementation of
HRV biofeedback for 4 weeks immediately after delivery
could contribute to reduction of the Edinburgh Postnatal
Depression Scale (EPDS), a standardized self-reported
questionnaire to identify women who have postpartum
depression (Cox et al. 1987). The EPDS has been shown to
be able to detect perinatal anxiety disorders as well (Mat-
they 2008; Matthey et al. 2013). Additionally, resting HRV
measures in each woman were evaluated as indicators of a
fundamental autonomic neural state, and impacts of HRV
biofeedback on the measures were assessed. Our hypoth-
esis was that implementation of HRV biofeedback imme-
diately after delivery would result in lower scores on the
EPDS and increased HRV measures at 1 month postpartum




The study protocol was approved by the Ethics Committee
of Akita University Graduate School of Medicine and the
Faculty of Medicine. Subjects were recruited from mothers
who gave birth at Akita University Hospital between
October 1, 2011 and September 30, 2013; recruitment took
place 4 days postpartum. Only healthy mothers who had
experienced vaginal deliveries of a single infant, without
any medical complications, were included. Mothers who
habitually drank alcohol or smoked were excluded. Written
informed consent was obtained from mothers who agreed
to participate in the study.
On postpartum day 4, subjects completed a question-
naire detailing demographic data, including age, gesta-
tional age, parity, height, and employment status. As a part
of a routine health checkup, body weight, blood pressure,
heart rate, and body temperature were measured. Around
4 days after birth, mothers often experience a transient
mental disorder called maternity blues. The Stein scale for
maternity blues (Stein 1980) was used to determine whe-
ther subjects suffered from this condition.
Heart Rate Variability Biofeedback
All subjects received a brief explanation about HRV bio-
feedback on postpartum day 4. If subjects agreed to use
HRV biofeedback at home, detailed directions regarding
how to implement HRV biofeedback using a portable
device (StressEraser, Helicor, Inc., New York, NY, USA)
were provided. This device records blood vessel pulse
waves in the index finger in real time and displays HRV as
a waveform on the screen. When users synchronize the
rhythm of their breathing with this waveform, they create a
resonance between breathing-induced HRV and HRV due
to Mayer waves from arterial pressure. When a resonance
is completely established, their HRV becomes maximized,
and parasympathetic tone is enhanced. The degree of
consistency between the HRV waveform on the screen and
breathing rhythm is shown on the screen in real time above
each individual waveform as a point display ranging from 1
to 3, with 3 points representing the best synchronization.
Subjects who agreed to implement HRV biofeedback
learned to use the device while they were in the hospital
and took the device home about 6 days after delivery.
According to instructions for the device, subjects were
recommended to undergo HRV biofeedback daily with a
score of 30 points or more per session and with a sufficient
number of sessions a day to achieve a total score of 100
points or more. They were also asked to record their
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performance daily on a provided chart. Subjects took part
in a telephone interview around 2 weeks after discharge to
check their compliance with HRV biofeedback. After
4 weeks, subjects visited our hospital for a routine 1-month
postnatal check-up. Subjects who did not agree to use
biofeedback served as the control group.
Heart Rate Variability Analysis
The resting HRV of all subjects was recorded on day 4 and
1 month postpartum by photoplethysmography (Heart
Rhythm Scanner, Biocom Technologies, Poulsbo, WA,
USA). Data were collected between 10:00 am and noon,
after subjects had confirmed that they had not eaten, drank,
or smoked during the previous 2 h. Subjects were
instructed to rest in the supine position for 5–10 min in a
quiet room and breathe slowly. Next, the heart rate scanner
optical ear clip sensor was attached to the pinna of the ear.
Pulse intervals were recorded for 5 min, during which
participants were requested to remain in the supine posi-
tion. Data were immediately uploaded to a personal com-
puter and HRV measures were calculated. The HRV
measures of interest included the standard deviation of the
normal heartbeat interval (SDNN), the high-frequency
(HF) power in the 0.15–0.4 Hz waveband, and the low-
frequency (LF) power in the 0.04–0.15 Hz wave band
(Task Force 1996).
Edinburgh Postnatal Depression Scale
On day 4 postpartum and at the 1-month postpartum
check-up at our hospital, mental state was assessed in all
subjects using the EPDS. The EPDS is a 10-item self-
rating questionnaire developed to detect probable
depression in the first 8 weeks after childbirth (Cox et al.
1987) and appears to detect perinatal anxiety disorders as
well (Matthey 2008; Matthey et al. 2013). Each item is
scored on a scale of 0–3, and the total score ranges from
0 to 30. A score C10 points indicates a high risk for
postpartum depression.
Each woman completed the EPDS by herself on day 4
postpartum, but the EPDS at the 1-month postpartum was
evaluated during a face-to face-interview with a clinical
psychologist who had no direct connection to this study;
all interviews took place in a private room. Because our
hospital has a rule requiring that all mothers be asked to
undergo an interview with a clinical psychologist 1 month
after giving birth, the subjects of this study were unaware
that the EPDS was being used as the study scale when
they were interviewed. After interview, we obtained
informed consent from each subject to use this score at
the 1-month postpartum for outcome measures in this
study.
Statistics
Statistical analyses were performed using the Statistical
Package for the Biosciences (Nankodo, Tokyo, Japan) or
IBM SPSS Statistics (version 21.0 Static Base and
Advanced Statistics, IBM Japan, Tokyo, Japan). Because
the distributions for HF power and LF power (the fre-
quency domain analysis values for HRV) approached a
normal distribution, logarithmic conversion was performed
before analysis. Intergroup comparisons and correlations
were analyzed by parametric or nonparametric methods
depending on whether or not data were normally distrib-
uted. Two-way factorial analysis of variance was used to
compare the repeated HRV measures between mothers who
underwent biofeedback with those who did not. Group
differences of HRV measures at 1 month postpartum were
examined by analysis of covariance, adjusted for maternal
age, parity, systolic blood pressure, and body mass index.
Data were expressed as mean ± SD, with P \ 0.05
regarded as statistically significant.
Results
Fifty-five mothers were approved to participate in this
study. Among them, 25 mothers who agreed to implement
HRV biofeedback were grouped as the biofeedback group,
and 30 mothers who did not want to use HRV biofeedback
were grouped as the control group. Table 1 presents com-
parisons of demographic factors, physical findings, and
HRV measures on postpartum day 4 between groups. There
were significant differences between groups in terms of
parity, gestational age, and systolic blood pressure. The
proportion of primiparous mothers was significantly higher
in the biofeedback group. Maternity blues was diagnosed in
16 mothers (29.1 %), and the proportion of affected
mothers was comparable between groups. There were no
significant differences in HRV measures or EPDS between
groups on postpartum day 4.
According to daily charts from mothers, all mothers in
the biofeedback group implemented at least one session of
HRV biofeedback every day, and 20 mothers (80 %)
achieved a total of 100 points in all sessions. Four mothers
reported that they could not achieve 100 points on about
2–5 days because they fell asleep while implementing
HRV biofeedback before a score reached that point. One
multiparous mother implemented HRV biofeedback and
achieved less than 100 points on most days because the
laborious care required for her older child.
Table 2 presents comparisons of HRV measures or
EPDS between groups from 4 days to 1 month postpartum.
All measures exhibited significant time-dependent changes
from 4 days to 1 month postpartum, including a decrease
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in heart rate, increases in other HRV measures, and a
decrease in EPDS. Significant interactive differences that
(group 9 time) change between groups were found for
heart rate, SDNN, HF power, and EPDS, indicating that
these measures changed in different ways between two
groups. Figure 1 presents changes of mean values of each
HRV measure or EPDS from 4 days to 4 weeks postpartum
in the two groups. The magnitude of changes in heart rate,
SDNN, and HF power appeared to be greater in the bio-
feedback group, as compared to those in the control group.
The time-course decrease in EPDS was observed in the
biofeedback group only.
Figure 2 presents distributions of EPDS in women at
one month postpartum. Distributions of all women
(n = 55) are presented in Fig. 2a, and only two women
scored C10, indicating a high risk for postnatal depression.
Distributions of women in each group are separately pre-
sented in Fig. 2b. In the biofeedback group, 22 of 25
mothers (88.0 %) presented the EPDS of below 5, and, in
the control group, 25 of 30 mothers (83.3 %) presented the
EPDS of above 4.
Table 3 presents comparisons of HRV measures and
EPDS (each item and total score) at 1 month postpartum
between groups. In terms of HRV measures after adjusting
for maternal age, parity, systolic blood pressure, and body
mass index, there were significant decreases in heart rate
and increases in SDNN in the biofeedback group compared
with the control group. There were significant differences
between groups in total EPDS score (P \ 0.001, Wilcoxon
test). Among the EPDS items, significant differences
between groups were found in three items related to anx-
iety (items 3–5), one item related to difficulty sleeping
(item 7) and one item related to sad and miserable feelings
(item 8). Only one woman in the biofeedback group and
one woman in the control group scored C10, indicating that
they were at high risk for postnatal depression.
Table 1 Comparisons of demographic factors, physical findings,
heart rate variability measures, and Edinburgh postnatal depression










Age (years) 30.5 ± 5.7 33.4 ± 6.6 0.086
Primiparous (number, %) 22 (88.9) 19 (65.3) 0.032
Gestational age (weeks) 39.1 ± 1.0 38.5 ± 0.8 0.030
Physical findings
Body mass index (kg/m2) 23.5 ± 3.1 24.1 ± 3.0 0.412
Systolic blood pressure
(mmHg)
109 ± 10 116 ± 12 0.023
Maternity blues 9 (38.9) 7 (23.1) 0.303
Heart rate variability measures
Heart rate (beats/min) 74.3 ± 7.5 77.1 ± 7.6 0.186
SDNN (ms) 38.7 ± 11.5 40.0 ± 16.8 0.743
HF power (log, ms2) 4.46 ± 0.94 4.69 ± 0.84 0.358
LF power (log, ms2) 4.59 ± 0.98 4.70 ± 1.00 0.684
Edinburgh postnatal depression scale
Total score 4.60 ± 1.99 4.20 ± 2.08 0.317b
Values are mean ± SD (range) or numbers (%)
SDNN standard deviation of normal-to-normal beat intervals, LF low
frequency, HF high frequency
a Group differences were examined by student t test or chi-square test
b Group differences were examined by Wilcoxon test
Table 2 Comparisons of heart
rate variability measures or
Edinburgh postnatal depression
scale from 4 days to 1 month
postpartum between the
biofeedback and control groups
Values are mean ± SD
SDNN standard deviation of
normal-to-normal beat intervals,
LF low frequency, HF high
frequency
a Values are F(P) of two-way






Timea Time 9 Groupa Groupa
F(1,53) P F(1,53) P F(1,53) P
Heart rate (beats/min)
Biofeedback 74.3 ± 7.5 63.1 ± 5.8 78.34 \0.001 8.30 0.006 11.67 0.198
Control 77.1 ± 7.6 71.4 ± 6.5
SDNN (ms)
Biofeedback 38.7 ± 11.5 57.2 ± 12.3 21.65 \0.001 12.41 0.001 5.26 0.090
Control 40.0 ± 16.8 42.5 ± 12.8
HF power (log, ms2)
Biofeedback 4.46 ± 0.94 5.45 ± 0.84 19.17 \0.001 4.89 0.031 0.46 0.501
Control 4.69 ± 0.84 5.01 ± 0.64
LF power (log, ms2)
Biofeedback 4.59 ± 0.98 5.32 ± 0.80 11.00 0.002 3.46 0.068 0.51 0.477
Control 4.70 ± 1.00 4.91 ± 0.95
Edinburgh Postnatal Depression Scale
Biofeedback 4.20 ± 2.08 2.56 ± 2.26 4.60 0.037 19.43 \0.001 7.68 0.008
Control 4.60 ± 1.99 5.17 ± 2.45
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Table 4 presents the correlation coefficients of total
EPDS with each HRV measure at 1 month postpartum in
all mothers (n = 55). The EPDS score exhibited a signif-
icant positive correlation with heart rate, and significant
negative correlations with SDNN and HF power (Spear-
man’s rank correlation test).
Discussion
EPDS scores at 1 month postpartum were significantly
lower in the biofeedback group than in the control group,
suggesting that use of HRV biofeedback after delivery
contributed to reduction of psychological stress in post-
partum women. Comparisons of each item in the EPDS
between groups showed that HRV biofeedback contributed
to alleviation of items related to anxiety (Matthey 2008)
and difficulty sleeping. Anxiety is probably among the
most common negative emotions for postpartum women.
In a community sample of 8,323 pregnant women,
approximately 15 % of women reported elevated anxiety in
the antenatal period, and rates were comparable in the
postnatal period (Heron et al. 2004). In fact, anxiety dis-
orders are more common than depressive disorders in the
perinatal period (Matthey et al. 2013). Therefore, reduction
of anxiety symptoms with HRV biofeedback, which was
reported by other studies (Reiner 2008; Henriques et al.
2011; Ratanasiripong et al. 2012), may be particularly
beneficial for postpartum women. HRV biofeedback was
reported to shorten sleep latency (Ebben et al. 2009),
prolong deeper sleep stages (Sakakibara et al. 2013), and
ameliorate insomnia (McLay and Spira 2009). Due to
childcare responsibilities, postpartum women sleep less
during the early weeks following delivery than during
pregnancy and other periods of the reproductive age (Lee
et al. 2000). These impaired sleep patterns are strongly
correlated with depressive symptoms in postpartum women
(Dørheim et al. 2009). Therefore, it is likely that sleep-
promoting effects of HRV biofeedback also contribute to
reduction of psychological stress in some postpartum
women.
Fig. 1 Mean ± SD of each HRV measure or Edinburgh Postnatal
Depression Scale from 4 days to 1 month postpartum in the
biofeedback (solid lines) and control (dash lines) groups. Significant
interactive differences (group 9 time) were found for heart rate,
SDNN, and HF power (see Table 2). SDNN standard deviation of
normal-to-normal beat intervals, LF low frequency, HF high
frequency, EPDS Edinburgh Postnatal Depression Scale
Fig. 2 Distribution of Edinburgh Postnatal Depression Scale in
women at 1 month postpartum. Distributions of all women (n = 55)
are presented in (a), and distributions of women in each group (black
bars for biofeedback, n = 25 and gray bars for control, n = 30) are
presented in (b)
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From 4 days to 1 month postpartum, there were signif-
icant reductions in heart rate and elevations in SDNN, HF
power, and LF power. HF power is an established index of
cardiac vagal tone, reflecting respiratory sinus arrhythmia.
Although LF power was previously thought to reflect car-
diac sympathetic outflow, several researchers believe that
the HRV power spectrum, including the LF component, is
mainly determined by the parasympathetic system (Grassi
and Esler 1999; Reyes del Paso et al. 2013). Therefore, we
regarded that increases in both LF and HF power would
reflect increased parasympathetic activity after delivery.
The magnitude of changes in heart rate, SDNN, and HF
power were larger in the biofeedback group, and thus,
HRV biofeedback may exaggerate parasympathetic acti-
vation during the early postpartum period. However, this
difference may also be attributable to the fact that the
demographics of subjects were biased. The biofeedback
group included a larger proportion of primiparous mothers
with relatively younger ages. The activation of parasym-
pathetic tone after delivery may be more evident among
younger, primiparous mothers. Therefore, we should attach
more importance to results showing significant group dif-
ferences in heart rate and SDNN at 1 month postpartum
after controlling for the influence of covariates, including
maternal age and parity.
There were significant positive correlations between
EPDS and heart rate, and negative correlations between
EPDS and both SDNN and HF powers. In general, low
HRV is thought to indicate decreased parasympathetic
activity. Therefore, a significant increase in resting SDNN,
the index of overall HRV, may indicate that use of HRV
biofeedback resulted in increased parasympathetic tone in
the resting state. However, the meaning attached to
increases in SDNN without increases in HF and/or LF
power in the present study should be carefully considered
because SDNN simply increases when heart rate decreases,
as was observed in the present study. Previously, several
studies analyzed HRV measures as an outcome of HRV
biofeedback, and significant increases in SDNN or LF
Table 3 Comparisons of heart rate variability measures and Edinburgh Postnatal Depression Scale (each item and total score) at 1 month








Heart rate variability measuresa
Heart rate (beats/min) 63.3 ± 5.4 71.2 ± 6.1 \0.001
SDNN (ms) 54.7 ± 10.7 44.6 ± 10.1 0.002
HF power (log, ms2) 5.38 ± 0.78 5.07 ± 0.48 0.110
LF power (log, ms2) 5.26 ± 0.78 4.96 ± 0.76 0.196
Edinburgh Postnatal Depression Scaleb
1. I have been able to laugh and see the funny side of things 0.04 ± 0.20 0.00 ± 0.00 0.290
2. I have looked forward to things with enjoyment 0.04 ± 0.20 0.10 ± 0.31 0.409
3. I have blamed myself unnecessarily when things went wrong 0.60 ± 0.50 1.23 ± 0.63 \0.001
4. I have been anxious or worried for no good reason 0.60 ± 0.65 1.00 ± 0.74 0.040
5. I have felt scared or panicky for no good reason 0.08 ± 0.11 0.60 ± 0.68 0.001
6. Things have been getting on top of me 0.96 ± 0.54 1.27 ± 0.58 0.050
7. I have been so unhappy that I have had difficulty sleeping 0.08 ± 0.28 0.37 ± 0.49 0.014
8. I have felt sad or miserable 008 ± 0.28 0.37 ± 0.49 0.014
9. I have been so unhappy that I have been crying 0.08 ± 0.28 0.13 ± 0.35 0.542
10. The thought of harming myself has occurred to me 0.00 ± 0.00 0.10 ± 0.31 0.112
Total score 2.56 ± 2.26 5.17 ± 2.45 \0.001
SDNN standard deviation of normal-to-normal beat intervals, LF low frequency, HF high frequency
a Group differences were examined by analysis of covariance, adjusted for maternal age, parity, systolic blood pressure, and body mass index
b Group differences were examined by Wilcoxon test
Table 4 Correlation coefficients of total Edinburgh Postnatal
Depression Scale with each heart rate variable measure in all mothers
at 1 month postpartum
Ra P
Heart rate (beats/min) 0.476 \0.001
SDNN (ms) -0.277 0.04
HF power (log, ms2) -0.357 0.008
LF power (log, ms2) -0.211 0.122
SDNN standard deviation of normal-to-normal beat intervals, LF low
frequency, HF high frequency
a Spearman’s rank correlation coefficient
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power during HRV biofeedback were constantly reported
(Lehrer et al. 2003; Karavidas et al. 2007; Hassett et al.
2007). However, although several studies investigated
whether there were carry-over effects of HRV biofeedback
on resting HRV, conclusions were inconsistent. Some
studies demonstrated positive impacts of HRV biofeedback
on resting HRV measures, such as SDNN (Zucker et al.
2009; Del Pozo et al. 2004) or LF power (Hallman et al.
2011), whereas other studies reported that the influences
were rare or nonexistent (Lehrer et al. 2003; Karavidas
et al. 2007; Siepmann et al. 2008; Swanson et al. 2009;
Henriques et al. 2011). Therefore, it may be true that
positive effects of HRV biofeedback cannot be clearly
explained by changes in daily autonomic functioning.
Wheat and Larkin (2010) stated that, because clinical and
physiological outcome do not improve concurrently, the
mechanism by which HRV biofeedback results in salutary
effects is still unclear.
Compliance with HRV biofeedback was high among
women in this study, with as many as 20 mothers (80 %)
achieving a total of 100 points or more in all sessions.
Clinical outcomes of the biofeedback group were favorable,
although it was probable that these effects resulted, in part,
from the intervention effects. In our experience, HRV bio-
feedback serves as a useful communication tool between
medical staff and mothers, as we noted that investigators and
some mothers using HRV biofeedback achieved a closer
relationship throughout this study. In another study, dizzi-
ness occurred in 15 % of 24 patients with anxiety disorders
who used HRV biofeedback, a side effect that may have
resulted from hyperventilation (Reiner 2008). No mothers in
this study complained about this symptom. Therefore, HRV
biofeedback is a feasible, effective, and safe intervention for
most postpartum women. Thus, if staff members recommend
HRV biofeedback with enthusiasm, a considerable number
of mothers may be willing to use this treatment. However, it
remains questionable whether HRV biofeedback is really
advantageous to healthy users. Lehrer and Eddie (2013)
stated that HRV biofeedback enhanced the negative feed-
back loop, including the baroreflex, but this might weaken
reflexes dependent on oscillations at other frequencies. This
raises the concern that frequent, long-term use of HRV
biofeedback may weaken adaptability of the physical control
system to external stressors. Therefore, for postpartum
women, it may be preferable to implement HRV biofeedback
for a relatively short period daily (about 20 min, as recom-
mended by Lehrer and Eddie 2013), and to limit the period of
HRV biofeedback to the first month after delivery, when
stress is most likely to occur.
Several limitations of the present study warrant discus-
sion. First, this was not a random study and demographics
were biased, although use of appropriate statistical analyses
was able to control for potential covariates to some extent.
Second, the resting HRV was recorded by photoplethys-
mography, not by electrocardiography, and thus, accuracy
of HRV measures was less than ideal. Third, subjective
influences may have occurred in the biofeedback group
when they answered questions from the EPDS interviewer,
and the decrease in EPDS in the biofeedback group may be
largely due to intervention effects. The absence of an active
control made it difficult to validate genuine effects of HRV
biofeedback. Forth, evaluation of individual stress levels
relying on single EPDS may be incorrect in some women,
and introduction of multilateral evaluation (e.g., simulta-
neous estimation of another stress scale or using bio-
chemical markers) may have provide more accurate
information on stress levels in postpartum women. Fifth,
our results do not indicate that HRV biofeedback contrib-
utes to a reduction in the risk of postpartum depression.
Our study subjects included only two women who scored
C10 on the EPDS, indicating a high risk for postnatal
depression. There is no evidence that a difference in scores
that fall within the normal range reflects a difference in the
actual risk for postpartum depression.
In conclusion, results in this study partially supported
our hypothesis that implementation of HRV biofeedback
immediately after delivery resulted in lower EPDS scores
and increased HRV measures at 1 month postpartum. The
mothers who used HRV biofeedback were relatively free
from anxiety and complained less of difficulties sleeping;
however, the lack of a random study design and an active
control group means that these findings should be inter-
preted with caution. HRV biofeedback intervention was
found to reduce heart rate and increase SDNN in the resting
period, but increases in SDNN without increases in HF or
LF powers provide inconclusive evidence of parasympa-
thetic activations. However, due to its clinical effectiveness
and feasibility, HRV biofeedback appears to be recom-
mendable for many postpartum women after childbirth,
especially when they are worried about upcoming changes
in routines and the responsibilities of childcare.
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